STOCK TITAN

Cocrystal Pharma, Inc. (COCP) Net Income by Year

COCP

Cocrystal Pharma, Inc. reported a net loss of $8.8M in fiscal year 2025. This represents an increase of 49.5% from the prior fiscal year. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters Cocrystal Pharma, Inc. has filed alongside them.

FY2025 annual
Net Income -$8.8M
YoY +49.5%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

COCP Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY25DEF 14AFY24DEF 14AFY23DEF 14AFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-KFY1310-KFY1210-KFY1110-K
Net Income-$8.8M+49.5%-$17.5M+2.7%-$18.0M+53.7%-$38.8M-173.8%-$14.2M-47.0%-$9.6M+80.0%-$48.2M+1.8%-$49.0M-7901.3%-$613K+99.2%-$74.9M-49.4%-$50.1M-50528.3%-$99K+97.5%-$3.9M+51.2%-$8.0M-45.9%-$5.5M

COCP Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
Net Income-$3.2M-54.0%-$2.3M+0.1%N/A-$2.0M+58.5%-$2.1M+61.5%-$2.3M+41.8%N/A-$4.9M-18.6%-$5.3M-28.3%-$4.0M+23.8%N/A-$4.2M+26.9%

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More Cocrystal Pharma, Inc. financials

Frequently Asked Questions

What was Cocrystal Pharma, Inc.'s net income in fiscal year 2025?

Cocrystal Pharma, Inc. reported a net loss of $8.8M in fiscal year 2025.

How fast is Cocrystal Pharma, Inc.'s net income growing?

Cocrystal Pharma, Inc. (COCP) net income rose by 49.5% year over year, from -$17.5M to -$8.8M in fiscal year 2025.

How has Cocrystal Pharma, Inc.'s net income changed over the years?

Across the 15 fiscal years this page covers, Cocrystal Pharma, Inc. (COCP) net income went from -$5.5M in fiscal year 2011 to -$8.8M in fiscal year 2025.

Cocrystal Pharma, Inc. (COCP) reported -$3.2M in net income in Q2 2026. This represents a decrease of 54.0% from the same quarter a year earlier.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Cocrystal Pharma, Inc. (COCP) reported on that line in every period on record.